Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

Autologous dendritic cell vaccines for non-small-cell lung cancer

Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

Dendritic cell vaccination in medullary thyroid carcinoma

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides